Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Terbinafine hydrochloride (Systemic)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Terbinafine 250mg tablets
0502050C0AAAAAA
|
Terbinafine hydrochloride (Systemic) | Terbinafine hydrochloride | Infections | 85,277 |
|
Terbinafine 250mg/5ml oral suspension
0502050C0AAAFAF
|
Terbinafine hydrochloride (Systemic) | Terbinafine hydrochloride | Infections | 326 |
|
Terbinafine 250mg/5ml oral solution
0502050C0AAAEAE
|
Terbinafine hydrochloride (Systemic) | Terbinafine hydrochloride | Infections | 57 |
|
Terbinafine 62.5mg/5ml oral liquid
0502050C0AAADAD
|
Terbinafine hydrochloride (Systemic) | Terbinafine hydrochloride | Infections | 1 |
|
Terbinafine 125mg/5ml oral liquid
0502050C0AAABAB
|
Terbinafine hydrochloride (Systemic) | Terbinafine hydrochloride | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.